Renato Skerlj - Net Worth and Insider Trading

Renato Skerlj Net Worth

The estimated net worth of Renato Skerlj is at least $49,019 dollars as of 2024-04-27. Renato Skerlj is the Chief Scientific Officer of X4 Pharmaceuticals Inc and owns about 42,076 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $49,019. Details can be seen in Renato Skerlj's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renato Skerlj has not made any transactions after 2020-09-09 and currently still holds the listed stock(s).

Transaction Summary of Renato Skerlj

To

Renato Skerlj Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renato Skerlj owns 1 companies in total, including X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Renato Skerlj’s form 4 insider trades.

Insider Ownership Summary of Renato Skerlj

Ticker Comapny Transaction Date Type of Owner
XFOR X4 Pharmaceuticals Inc 2020-09-09 Chief Scientific Officer

Renato Skerlj Latest Holdings Summary

Renato Skerlj currently owns a total of 1 stock. Renato Skerlj owns 42,076 shares of X4 Pharmaceuticals Inc (XFOR) as of September 9, 2020, with a value of $49,019.

Latest Holdings of Renato Skerlj

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2020-09-09 42,076 1.17 49,019

Holding Weightings of Renato Skerlj


Renato Skerlj Form 4 Trading Tracker

According to the SEC Form 4 filings, Renato Skerlj has made a total of 1 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in X4 Pharmaceuticals Inc is the sale of 5,834 shares on September 9, 2020, which brought Renato Skerlj around $46,964.

Insider Trading History of Renato Skerlj

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renato Skerlj Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Renato Skerlj Ownership Network

Ownership Network List of Renato Skerlj

No Data

Ownership Network Relation of Renato Skerlj


Renato Skerlj Owned Company Details

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Renato Skerlj is the Chief Scientific Officer of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include Chief Scientific Officer Arthur Taveras , Chief Operating Officer Mary Dibiase , and See Remarks Adam S. Mostafa .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Renato Skerlj made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 185,708 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 185,708 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

Renato Skerlj Mailing Address

Above is the net worth, insider trading, and ownership report for Renato Skerlj. You might contact Renato Skerlj via mailing address: C/o X4 Pharmaceuticals, Inc., 955 Massachusetts Avenue, 4th Floor, Cambrige Ma 02139.

Discussions on Renato Skerlj

No discussions yet.